Guidelines for the prevention of sudden cardiac death have been revised by the Task Force on Sudden Cardiac Death of the European Society of Cardiology

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.399, 2003-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic developments in sudden cardiac death

By Goldberger J.J.   Neelagaru S.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 11, 2000-11 ,pp. : 2543-2554

Informa Healthcare

Access to resources Recommend Favorite

Risk of sudden cardiac death with commonly prescribed drugs

By  

Reactions Weekly, Vol. 1, Iss. 1052, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Calstabin2 – a new target in sudden cardiac death

By Doggrell Sheila A  

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 6, 2004-12 ,pp. : 663-665

Informa Healthcare

Access to resources Recommend Favorite

Sudden cardiac death secondary to antidepressant and antipsychotic drugs

By Sicouri Serge   Antzelevitch Charles  

Expert Opinion on Drug Safety, Vol. 7, Iss. 2, 2008-03 ,pp. : 181-194

Informa Healthcare

Access to resources Recommend Favorite

Quetiapine overdose: Sudden cardiac death: case report

By  

Reactions Weekly, Vol. 1, Iss. 1431, 2012-01 ,pp. : 34-34

Adis International

Access to resources Recommend Favorite